Considering the mcap of >$40m prior these results are terrible and exacerbated by the following:
- "Principal lithium minerals identified during geological logging of diamond drill core include spodumene, lepidolite, zinnwaldite, garnet, tourmaline (elbaite) supporting the potential of Bonzer to host significant lithium mineralisation"
lepidolite and zinnwaldite are lithium minerals, but NOT the lithium minerals you want due to issues with processing. Spodumene is really the only mineral you want, so if the already low lithium grades received today are mainly from lepidolite and zinnwaldite, then the results are even worse than reported as effectively you would be subtracting the lithium amounts contained in these 2 minerals from the lithium contained in spodumene.
- their surface soils and rock chips were very good so to get such low grade lithium results in drilling doesn't bode well for future drilling on other pegmatites.
- they mention the K/RB ratio is important for assessing pegmatite fertility and then intentionally leave out Rb from their results so that this ratio can't be calculated lolRb is almost always shown along with the Li grade for all other companies as it also shows the association with mica and hence lepidolite..very sus!
Based on the above you'd need something close to a miracle to actually hit economic mineralisation in further drill campaigns imo.
If only there was someone with a bit of knowledge/experience to warn holders they were likely in for a spanking when results were released.
- Forums
- ASX - By Stock
- RR1
- Ann: Initial Drilling Confirms Lithium System
RR1
reach resources limited
Add to My Watchlist
12.5%
!
0.9¢

Ann: Initial Drilling Confirms Lithium System, page-44
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.9¢ |
Change
0.001(12.5%) |
Mkt cap ! $7.869M |
Open | High | Low | Value | Volume |
0.8¢ | 0.9¢ | 0.7¢ | $30.42K | 3.826M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 250000 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 2071266 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 250000 | 0.008 |
16 | 17969648 | 0.007 |
14 | 8182140 | 0.006 |
4 | 2500000 | 0.005 |
7 | 5327500 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 2071266 | 3 |
0.010 | 2246828 | 8 |
0.011 | 63163 | 2 |
0.012 | 948460 | 2 |
0.013 | 484762 | 2 |
Last trade - 14.38pm 27/06/2025 (20 minute delay) ? |
Featured News
RR1 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online